wild-type controls (BZRWT) (n=ZO) were studied. Half the mice in each group were treated with Sim (ZOmg/kg/day oral) for 6 weeks. 2D echocardiography was performed at baseline and 6 weeks to measure cardiac function and dimensions. At 6 weeks, eNOS, phospho-eNOS and phospho-AM expression was measured in myocardium. Myocardial sections were stained to detect eNOS in microvessels. 
(9.6*0.4 vs 8.0i0.5 ml/m2), LV end-systolic diameter (16.3+0.9 vs 13.4+0.6 crnIm2) and decrease in LV shortening fraction (SF 48+2% vs 57i2%) (p.zO.05 vs WT). Sim treatment lowered LV mass (5.6~2 mg/m2), volume (6.2kO.3 mllm2). systolic diameter (1. 4iO.5) and increased SF (57*1%) in KO mice compared to untreated group (p<O.Ol). Sim did not alter LV function in WT mice. eNOS expression was preserved in KO mice. PhosphoeNOS expression was lower in KO mice compared to Wl (p=O.O5). Sim treatment decreased eNOS (p=O.O06) but increased phospho-eNOS expression (~~0.05) compared to untreated KO. Phospho-Akt, which phosphorylates eNOS, was also higher in the Sim treated KO. lmmunostaining localized eNOS to the coronary vascular endothelium in both KO and WT mice.
Conclusion:
Disruption of the BZR results in reduced eNOS activation and progressive cardiac remodeling and dysfunction. Sim reduces contractile dysfunction and cardiac remodeling by increasing AM-mediated eNOS phosphotylation. Since B2R and eNOS expression is reduced in human heart failure, this novel effect of Sim may be pote$ally beneficial in the treatment of heart failure.
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Methods
We studied an ovine model of anteroapical myocardial infarction (MI) that results in CHF wer 6 weeks. Contrast echocardiography was used to image the lefl ventricle (LV) in long-axis. In the ventricular septum, a discrete infarct line (red in figure) could be seen in all animals (n=4) at 1 hr postinfarction. The BZ was defined as the contrast-perfused myocardium adjacent to this infarct line. The wall thickness (h) and the LV endocardial curvature (K) were determined at end systole (ES) before and after infarction.
Results
The BZ endocardial contour was concave towards the cavity at baseline, with K = 0.26 cm-' t 0.06 cm'. Postinfarction. BZ endccardial contour was convex towards the cavity, with K = 0.61 cm-' + 0.15 cni'(p < .Ol). BZ h increased from 1.06 cm f 0.17 cm at baseline to 1.27 cm f 0.21 cm at 1 hr (p < 0.05).
Conclusion
In a model of progressive LV remodeling, geometric changes consistent with decreased series resistance and increased load-derived wall stress were measured in the BZ immediately after MI. These findings suggest that alterations in LV conformation contribute to BZ expansion, and that contrast echocardiographic studies may allow prediction of progresswe LV remodeling and CHF. Previous studies suggested that autologous skeletal myoblast tansplantation (ASMT) improves left ventricular (LV) function in small animals following myocardial infarction. We tested the effects of ASMT on hemodynamics and LV function in repeated coronary microembolization-induced chronic heart failure (CHF) in conscious dogs. ?? ackgrounti Pos-infarct congestive heart failure is a leading cause of death in developed and developing countries. The heart failure results from the extensive cell death and the remodeling process that takes place after the infarct. Published work using cell therapies to reconstitute damaged ischemic hearts has focused on animal models of acute infarction. Cellular cardiomyoplasty (CCM) has improved heart function in these cases. However the efficiency of cell therapies in chronic myocardlal infarcts has not been tested. We have now applied bone marrow stromal cell (MSC) therapy to a model of healed infarct in rats. Methods and Results: lnbread Male Wistar rats (200 to 2509) were anesthetized and the left anterior descending artery was ligated. Four weeks after surgery the rats were submitted to CCM. We injected 2O@L of suspension containing 2 to 5 X ld MSC or culture medium (CM) into the scar tissue. In order to perform a functional assessment, the rats were submitted to electro (ECG) and echocardiography (ECO) two weeks after CCM. The ECG was recorded in the following groups: non-operated (n=50), sham-operated (we), infarcted (n=l9) and infarcted and treated wth CM (n=6) or MSC (n=7). The EC0 was performed in normal (n=6). sham (n=5). infracted 
